Gary Jacob
Algemeen Directeur bij OKYO PHARMA LIMITED
Vermogen: 67 180 $ op 30-04-2024
Actieve functies van Gary Jacob
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Directeur/Bestuurslid | 23-12-2020 | - |
| Independent Dir/Board Member | 23-12-2020 | - | |
| OKYO PHARMA LIMITED | Directeur/Bestuurslid | 07-01-2021 | - |
| Algemeen Directeur | 07-01-2021 | - |
Loopbaan van Gary Jacob
Eerdere bekende functies van Gary Jacob
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| HEPION PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 15-05-2013 | 19-03-2014 |
| Algemeen Directeur | 15-05-2013 | 19-03-2014 | |
| Voorzitter | 19-03-2014 | 20-02-2024 | |
| Independent Dir/Board Member | 19-03-2014 | 20-02-2024 | |
| President | 15-05-2013 | 19-03-2014 | |
| VIRPAX PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 28-04-2020 | 25-07-2022 |
| Independent Dir/Board Member | 28-04-2020 | 25-07-2022 | |
| IMMURON LIMITED | Directeur/Bestuurslid | 17-04-2019 | 25-03-2020 |
| Algemeen Directeur | 16-11-2018 | 25-03-2020 | |
| SYNERGY PHARMACEUTICALS INC | Directeur/Bestuurslid | 29-03-2011 | 05-05-2014 |
| Algemeen Directeur | 01-07-2008 | 19-12-2017 | |
| Voorzitter | 05-05-2014 | 01-01-2018 | |
| Oprichter | - | 01-01-2018 | |
| Investor Relations Contact | 29-03-2011 | 06-05-2014 | |
| Public Communications Contact | 24-08-2011 | 06-05-2014 | |
| President | 01-07-2008 | 19-12-2017 | |
| Synergy Pharmaceuticals, Inc. /Old/ | Algemeen Directeur | 01-07-2008 | 01-10-2017 |
| Voorzitter | 01-09-2013 | 01-10-2017 | |
| Oprichter | 01-07-2008 | 01-10-2017 | |
| President | 01-07-2008 | 01-10-2017 | |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Directeur/Bestuurslid | 01-05-2003 | 22-01-2013 |
| Algemeen Directeur | 01-05-2003 | 22-01-2013 | |
| Hoofd Techniek/Wetenschap/O&O | 01-05-2003 | 22-01-2013 | |
| Public Communications Contact | 01-05-2003 | 22-01-2013 | |
| President | 01-01-2004 | 22-01-2013 | |
| Pawfect Foods, Inc. | Directeur/Bestuurslid | 11-08-2008 | 11-08-2008 |
| President | - | 11-08-2008 | |
| ░░░░░░░ ░░ | ░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - | |
| ░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Gary Jacob
| University of Wisconsin | Doctorate Degree |
| University of Missouri-St. Louis | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 14 |
| Verenigd Koninkrijk | 3 |
| Australië | 2 |
Operationeel
| Director/Board Member | 9 |
| Chief Executive Officer | 6 |
| President | 5 |
Sectoraal
| Health Technology | 10 |
| Consumer Services | 4 |
| Retail Trade | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 6 |
|---|---|
| CARDIFF ONCOLOGY, INC. | Health Technology |
| HEPION PHARMACEUTICALS, INC. | Health Technology |
| IMMURON LIMITED | Health Technology |
| VIRPAX PHARMACEUTICALS, INC. | Health Technology |
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| OKYO PHARMA LIMITED | Health Technology |
| Bedrijven in privébezit | 7 |
|---|---|
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
| Synergy Pharmaceuticals, Inc. /Old/ | Health Technology |
Synergy Pharmaceuticals LLC
 Synergy Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Synergy Pharmaceuticals LLC engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai and is headquartered in New York, NY. | Health Technology |
| Pawfect Foods, Inc. | Retail Trade |
| Synergy DE | |
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
| G.D. Searle LLC |
- Beurs
- Insiders
- Gary Jacob
- Ervaring
